Are men at greater risk for Parkinson’s disease than women?
By G. Wooten, L. Currie, V. Bovbjerg, J. K. Lee, J. Patrie. Journal of Neurology Neurosurgery & Psychiatry, 2004
720 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Complementary and alternative medicine, Neurology
View Paper: https://www.semanticscholar.org/paper/f915832eb857400e3f6892529426c202310290dc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
Citations in the corpus
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. (2009, background): “5 : 1 which is comparable to the published range of 3:2 (Wooten et al., 2004).”
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence (2011, background): “95) [55].”
- Sex-specific genetic architecture of human disease (2008, background): “, whereas schizophrenia, Parkinson disease and colorectal cancer are more common in me”
- Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease (2012, background): “Nevertheless, the increased prevalence rate with increasing age and the higher prevalence in men are well recognized, and reporting is therefore usually stratified by age and gender.(2,55)”
- Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019 (2021, background): “Furthermore, estrogen had potential neuroprotective effects for females (27).”